Search Results

There are 16460 results for: content related to: Pilot study of pegylated interferon-alpha 2a in dialysis patients with chronic hepatitis C virus infection

  1. You have free access to this content
    Telaprevir and pegylated interferon–alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients

    Hepatology

    Volume 46, Issue 3, September 2007, Pages: 631–639, Tara L. Kieffer, Christoph Sarrazin, Janice S. Miller, Martin W. Welker, Nicole Forestier, Hendrik W. Reesink, Ann D. Kwong and Stefan Zeuzem

    Version of Record online : 6 AUG 2007, DOI: 10.1002/hep.21781

  2. Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C in HIV-infected patients with haemophilia

    Haemophilia

    Volume 16, Issue 3, May 2010, Pages: 502–507, R.-F. ZHANG, H.-Q. SUN, Q. HUANG, J.-R. WANG, X.-X. ZHANG, X.-N. LIU, Q. MA and H.-Z. LU

    Version of Record online : 20 DEC 2009, DOI: 10.1111/j.1365-2516.2009.02170.x

  3. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  6. Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 17, Issue 6, June 2010, Pages: 410–418, S. S. Tan, M. R. Abu Hassan, A. Abdullah, B. P. Ooi, T. Korompis and M. I. Merican

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1365-2893.2009.01191.x

  7. Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

    Journal of Viral Hepatitis

    Volume 14, Issue 6, June 2007, Pages: 396–403, Y. Asahina, N. Izumi, N. Umeda, T. Hosokawa, K. Ueda, F. Doi, K. Tsuchiya, H. Nakanishi, K. Matsunaga, T. Kitamura, M. Kurosaki, M. Uchihara, M. Higaki and S. Miyake

    Version of Record online : 25 AUG 2006, DOI: 10.1111/j.1365-2893.2006.00803.x

  8. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  9. You have free access to this content
    Liver–kidney recipients with chronic viral hepatitis C treated with interferon-alpha

    Transplant International

    Volume 25, Issue 9, September 2012, Pages: 941–947, Qussai Hassan, Bruno Roche, Camille Buffet, Thomas Bessede, Didier Samuel, Bernard Charpentier and Antoine Durrbach

    Version of Record online : 6 AUG 2012, DOI: 10.1111/j.1432-2277.2012.01520.x

  10. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  11. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b

    Journal of Viral Hepatitis

    Volume 13, Issue 12, December 2006, Pages: 811–820, A. Abergel, C. Hezode, V. Leroy, K. Barange, J. P. Bronowicki, A. Tran, L. Alric, L. Castera, P.-H. Bernard, C. Henquell, H. Lafeuille, S. Ughetto, C. Darcha, M. Chevallier, N. Martineau, S. Dubost, K. Randl, D. Dhumeaux, G. Bommelaer, C. Bonny and a French multicenter study group

    Version of Record online : 5 JUL 2006, DOI: 10.1111/j.1365-2893.2006.00768.x

  12. You have full text access to this OnlineOpen article
    Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial

    Journal of Viral Hepatitis

    Volume 14, Issue 11, November 2007, Pages: 788–796, Th. Witthöft, B. Möller, K. H. Wiedmann, St. Mauss, R. Link, J. Lohmeyer, M. Lafrenz, C. M. Gelbmann, D. Hüppe, C. Niederau and U. Alshuth

    Version of Record online : 16 MAY 2007, DOI: 10.1111/j.1365-2893.2007.00871.x

  13. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  14. Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 7pt1, July 2008, Pages: 1094–1104, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Yuichi Tanabe, Akihide Masumoto, Toshihiro Maruyama, Makoto Nakamuta, Munechika Enjoji, Koichi Azuma, Junya Shimono, Hironori Sakai, Shinji Shimoda, Jun Hayashi and Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 3 FEB 2008, DOI: 10.1111/j.1440-1746.2008.05319.x

  15. Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 1, January 2009, Pages: 28–35, A. Andriulli, C. Cursaro, R. Cozzolongo, A. Iacobellis, M. R. Valvano, A. Mangia, N. Minerva, D. Bacca, M. Stanzione, A. Scuteri, G. Montalto and P. Andreone

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01044.x

  16. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 401–411, Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz and Mona Metaoei

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02435.x

    Corrected by:

    CORRIGENDA

    Vol. 31, Issue 4, 588, Version of Record online: 17 FEB 2011

  17. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  18. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis

    Journal of Viral Hepatitis

    Volume 14, Issue 4, April 2007, Pages: 239–248, N. J. Shire, J. A. Welge and K. E. Sherman

    Version of Record online : 20 NOV 2006, DOI: 10.1111/j.1365-2893.2006.00824.x

  19. You have free access to this content
    Poster

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue S3, November 2014, Pages: 51–313,

    Version of Record online : 13 NOV 2014, DOI: 10.1111/jgh.12766_2

  20. You have free access to this content
    Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin

    Hepatology

    Volume 59, Issue 6, June 2014, Pages: 2101–2109, Teresa Santantonio, Massimo Fasano, Evangelista Sagnelli, Paolo Tundo, Sergio Babudieri, Paolo Fabris, Mario Toti, Giovanni Di Perri, Nicoletta Marino, Eligio Pizzigallo, Gioacchino Angarano and the Acute Hepatitis C Study Group

    Version of Record online : 29 APR 2014, DOI: 10.1002/hep.26991